Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Active, not recruiting · NCT04541212 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT04541212 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Montreal Heart Institute | 31 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier de l'université de Montréal (CHUM) | Montreal | Canada | 3 |
| CISSSS de Lanaudière_Hôpital Pierre LeGardeur (referring site) | Terrebonne | Canada | 1 |
| CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont | Montreal | Canada | 1 |
| CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital | Montreal | Canada | 1 |
| CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital | Montreal | Canada | 1 |
| Montreal Heart Institute | Montreal | Canada | 12 |